Dai Kishida Mitsuto Sato Chinatsu Kobayashi Ken-Ichi Ueno Tomomi Kinoshita Minori Kodaira Yasuhiro Shimojima Wataru Ishii Atsuhito Ushiki Shu-Ichi Ikeda
10.2169/internalmedicine.56.8053
Intern Med
2017;56(10):1253-1257.
mycobacterium abscessus clarithromycin cutaneous lesion resistance systemic lupus erythematosus
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28502947/
Anti-Bacterial Agents / therapeutic use Clarithromycin / therapeutic use Lupus Erythematosus, Systemic / complications Lupus Erythematosus, Systemic / drug therapy Mycobacterium Infections, Nontuberculous / drug therapy Mycobacterium Infections, Nontuberculous / etiology Nontuberculous Mycobacteria / drug effects
Anti-Bacterial Agents / therapeutic use Clarithromycin / therapeutic use Lupus Erythematosus, Systemic / complications Lupus Erythematosus, Systemic / drug therapy Mycobacterium Infections, Nontuberculous / drug therapy Mycobacterium Infections, Nontuberculous / etiology Nontuberculous Mycobacteria / drug effects Case Reports Adult Female Humans Immunocompromised Host / drug effects Mycobacterium Infections, Nontuberculous / microbiology Treatment Outcome Anti-Bacterial Agents Clarithromycin
PMC5491827
28502947
Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus
2017